Menthol & Wintergreen Cream
Authorisation PA0206/022/001 · Ovelle Limited
- Licence holder
- Ovelle Limited (all products →)
- Active substances
- Turpentine oil, Oleoresin capsicum, Methyl salicylate, Levomenthol
- Dosage form
- Cream
- Route of administration
- Topical use
- ATC code
- M02AC
- First authorised
- 01/09/1988
- Prescription status
- Product not subject to medical prescription
- Supply
- Supply through pharmacies only
- Legal basis
- Well-established use application (Article 10a of Directive No 2001/83/EC)
Turpentine oil: supply and approvals
3 authorised products on the HPRA list contain Turpentine oil. Shortage records below are for the substance in the EU, US and German markets and may not affect this Irish product; for Irish supply, check with the HPRA or a pharmacist.
- EU shortage (EMA)
- No entry in the EMA shortage catalogue (checked 18 Nov 2026)
- US shortage (FDA)
- No entry in the FDA drug shortage list (checked 18 Nov 2026)
- Germany (BfArM)
- No entry in the BfArM supply notices (checked 18 Nov 2026)
Registers: EU shortages · US shortages · German shortages · EMA approvals
Oleoresin capsicum: supply and approvals
1 authorised product on the HPRA list contains Oleoresin capsicum. Shortage records below are for the substance in the EU, US and German markets and may not affect this Irish product; for Irish supply, check with the HPRA or a pharmacist.
- EU shortage (EMA)
- No entry in the EMA shortage catalogue (checked 18 Nov 2026)
- US shortage (FDA)
- No entry in the FDA drug shortage list (checked 18 Nov 2026)
- Germany (BfArM)
- No entry in the BfArM supply notices (checked 18 Nov 2026)
Registers: EU shortages · US shortages · German shortages · EMA approvals
Methyl salicylate: supply and approvals
3 authorised products on the HPRA list contain Methyl salicylate. Shortage records below are for the substance in the EU, US and German markets and may not affect this Irish product; for Irish supply, check with the HPRA or a pharmacist.
- EU shortage (EMA)
- No entry in the EMA shortage catalogue (checked 18 Nov 2026)
- US shortage (FDA)
- No entry in the FDA drug shortage list (checked 18 Nov 2026)
- Germany (BfArM)
- No entry in the BfArM supply notices (checked 18 Nov 2026)
Registers: EU shortages · US shortages · German shortages · EMA approvals
About this licence
National authorisation (PA). A product authorisation granted by the HPRA for the Irish market. It has been authorised for 38 years (since 1 September 1988). The HPRA list marks it as marketed in Ireland.
Other medicines with Turpentine oil in Ireland
2 other products on the HPRA list contain Turpentine oil, from 2 licence holders; 2 of them are marked as marketed. Products with the same substance can differ in strength, form, other ingredients and what they are licensed for, so they are not automatically interchangeable.
| Medicine | Licence holder | Licence | Status |
|---|---|---|---|
| Mentholatum Deep Heat Cream | The Mentholatum Company (Ireland) Limited | National authorisation (PA) | Marketed |
| Vicks Vaporub Inhalation Vapour, Ointment Levomenthol 2.75% w/wCamphor 5.00% w/wEucalyptus Oil 1.50% w/w Turpentine Oil 5.00% w/w | WICK Pharma - Zweigniederlassung der Procter & Gamble GmbH | National authorisation (PA) | Marketed |
Other medicines with Oleoresin capsicum in Ireland
No other product on the HPRA list contains Oleoresin capsicum.
Other substances in ATC group M02AC
The ATC system groups medicines by the part of the body they act on and their chemistry. On the HPRA list, 5 other active substances share the group M02AC with this product:
Racementhol (1) · Eucalyptus oil (1) · Ethyl salicylate (1) · Hydroxyethyl Salicylate (1) · Methyl nicotinate (1)
Numbers in brackets are products on the HPRA list. Sharing an ATC group does not mean two medicines can replace each other.
The licence holder
Ovelle Limited holds 14 products on the HPRA list, with 16 different active substances; 14 of the products are marked as marketed.
This listing is regulatory information, not medical advice — consult the package leaflet, SPC, or a healthcare professional. For the authoritative record see the HPRA register.
How this page is built
The facts on this page are pulled directly from the HPRA's (Health Products Regulatory Authority) official open dataset — they are not written from memory, and nothing here is summarised or edited. Each field below names the dataset it came from, so you can check it yourself.
- HPRA Authorised Medicines List (open data) ↗ Licence number, holder, active substance(s), dosage form, route, ATC code(s), authorisation date and prescription status for this product
This page is built automatically: a daily sync job downloads HPRA's published XML export and copies the licence number, holder, active substance(s), dosage form, route, ATC code(s), authorisation date and prescription status directly into this page — no AI drafting and no per-product editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The HPRA data on this page was last retrieved on 19 Nov 2026. How every register is built: methodology · fixes we have made: corrections log.